|
Volumn 33, Issue 6, 2014, Pages 669-671
|
The impact of an infectious diseases consultation on antimicrobial prescribing
a a b c c b b d e e f g h h,i j a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPHOTERICIN;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
BETA LACTAM ANTIBIOTIC;
BETA LACTAMASE INHIBITOR;
CARBAPENEM;
CEPHALOSPORIN;
COTRIMOXAZOLE;
ECHINOCANDIN;
FOSCARNET;
GANCICLOVIR;
LINCOSAMIDE;
MACROLIDE;
PENICILLIN DERIVATIVE;
POLYPEPTIDE ANTIBIOTIC AGENT;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ANTIBIOTIC PROPHYLAXIS;
ANTIBIOTIC THERAPY;
COMMUNITY ACQUIRED INFECTION;
CONSULTATION;
CONTROLLED STUDY;
HOSPITAL INFECTION;
HUMAN;
INAPPROPRIATE PRESCRIBING;
INFECTION;
INTENSIVE CARE UNIT;
LETTER;
MAJOR CLINICAL STUDY;
MEDICAL DECISION MAKING;
PEDIATRIC HOSPITAL;
PRESCRIPTION;
PRIORITY JOURNAL;
COMMUNICABLE DISEASES;
HOSPITAL;
PATIENT REFERRAL;
STATISTICS AND NUMERICAL DATA;
TERTIARY CARE CENTER;
COMMUNICABLE DISEASES;
HOSPITALS, PEDIATRIC;
HUMANS;
REFERRAL AND CONSULTATION;
TERTIARY CARE CENTERS;
|
EID: 84901378771
PISSN: 08913668
EISSN: 15320987
Source Type: Journal
DOI: 10.1097/INF.0000000000000285 Document Type: Letter |
Times cited : (6)
|
References (2)
|